The World Health Organization (WHO) has changed the classification for the controversial three-month contraceptive injection depot medroxyprogesterone acetate - commonly known as Depo Provera - stating it poses no HIV risk, to the dismay of local women and experts. File Picture.
Sinovuyo Mbatani
Recent findings from a study conducted in England by medical professionals have shed light on the potential impact of contraceptive pills and injections on the brain.
According to a Sky News report, women using contraceptives such as Depo-Provera may face an increased risk of developing meningioma, a type of brain tumour.
This tumour typically grows on the meninges, the outer layer covering the brain and spinal cord.
The implications extend beyond mere physical effects, as these contraceptives also seem to influence the prefrontal cortex, a critical brain region responsible for regulating emotions.
The result? Heightened risks of depression, anxiety, and other emotional disturbances, as highlighted by recent studies and reports from News24 and News Medical & Life Science.
Despite the vital role of reproductive health in women's lives, it remains an under-researched field, with limited options for safe and less intrusive contraception.
While this study underscores the importance of informed decision-making, it does not advocate for discontinuing contraceptive use without consulting a healthcare professional.
According to medical observers, it is crucial for women to engage in open discussions with their healthcare providers, thoroughly exploring the potential side effects and alternatives available before committing to any form of contraception.
Ultimately, informed choices pave the way for safer and more effective family planning strategies.
IOL NEWS